Mahtab Shardi·Nov 2FDA 21 CFR Compliance: Why Signed Records Can Still Leave Critical GapsEvery SOP is approved. Every batch record is complete.Every required signature is in place. So why might the release decision still be…
Mahtab Shardi·Oct 12Pharmaceutical Risk Assessment Isn’t Just Paperwork: What GMP Teams Must ProveThe risk assessment is approved, every box is checked, every signature is in place, but can anyone prove the controls work?
Mahtab Shardi·Oct 5Your Pharmaceutical Risk Assessment May Look Complete, That Does Not Mean the Risk Is ControlledMost pharmaceutical risk assessments fail long before anyone enters a number into a matrix.
Ershadmoradi·Sep 14Pharmaceutical Validation Services: From IQ/OQ/PQ to Process, CSV and CQVA validation project can fail long before testing begins. Weak requirements, unclear acceptance criteria, or incomplete traceability can…
InSEOBUK blog — 서북 블로그byJessicayang·Sep 14“배려라는 마음을 가이드라는 도구로 담아냅니다” — 서북 PGM의 첫 번째 이야기“서로 배려하며 소통합시다.”
Anabiotec·Sep 2Potency assay development for biopharmaceuticals: From identification of mechanism-of-action to GMP…A therapeutic protein can sit at the correct concentration, pass every identity and purity test, and still fail to produce the effect it…
Ershadmoradi·Aug 24Choosing GMP Compliance Software in 2026: A Practical Guide for Pharma Quality TeamsPharmaceutical companies are steadily replacing paper records, spreadsheets, shared folders, and disconnected applications with controlled…
Mahtab Shardi·Jul 6FDA and EMA Don’t Fail Companies Over Paperwork, They Fail Weak Quality SystemsPharmaceutical companies do not fail GMP inspections only because one document looks weak or one room looks uncontrolled. In many cases…A response icon1A response icon1
Mahtab Shardi·Jul 1Everyone Talks About PQM, Few Know Where It’s Actually LearnedAt first glance, PQM looks like a straightforward abbreviation that you can simply “look up.” But in practice, anyone who has worked across…